Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Leukemia & Lymphoma|June 25, 2016
FDG-PET is prognostic and predictive for progression-free survival in relapsed follicular lymphoma: exploratory analysis of the GAUSS studyLale Kostakoglu, Andre Goy, Giovanni Martinelli, et al.
Investigative Ophthalmology & Visual Science|March 2, 2016
Biomarkers in Ocular Chronic Graft Versus Host Disease: Tear Cytokine- and Chemokine-Based Predictive ModelLidia Cocho, Itziar Fernández, Margarita Calonge, et al.
Advances in Rheumatology (London, England)|August 23, 2022
Graft versus host disease-related eosinophilic fasciitis: cohort description and literature reviewCristina Hidalgo Calleja, Daniel Martín Hidalgo, Concepción Román Curto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2016
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO TrialMonica Cabrero, Alejandro Martin, Javier Briones, et al.
Blood|February 28, 2002
Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcomeJesús F San Miguel, Julia Almeida, Gema Mateo, et al.
British Journal of Haematology|June 19, 2013
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patientsTeresa Caballero-Velázquez, Lucia López-Corral, Cristina Encinas, et al.
British Journal of Haematology|March 31, 2015
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplantJorge Labrador, Lucia López-Corral, Lourdes Vazquez, et al.
Haematologica|July 21, 2007
The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphomaJosé Rodríguez, Eulogio Conde, Antonio Gutiérrez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host diseaseManuel Jurado, Carlos Vallejo, José A Pérez-Simón, et al.
Biomarker Research|October 4, 2014
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphomaFrancine Foss, Bertrand Coiffier, Steven Horwitz, et al.
Pageof 16